Matches in SemOpenAlex for { <https://semopenalex.org/work/W4379285871> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W4379285871 endingPage "e14041" @default.
- W4379285871 startingPage "e14041" @default.
- W4379285871 abstract "e14041 Background: The gender, age and family history of patients are important factors leading to the mutation of tumor-related genes. Currently, the relationship between these factors and tumor gene mutations in glioma is unclear. Therefore, we identified the effect of gender, age, and family history on cancer-susceptibility gene mutations in patients with glioma through retrospective analysis. Methods: A total of 735 FFPE tissue samples were collected from 2019 to 2022 in glioma patients, and sequenced by HapOnco StarPanel NGS Assay (covering 1326 genes + 3 viral sequences). Results: (1) These mutations were categorized into four subgroups according to the age of the patients. In the 0-20 years group, the main mutated genes were TP53 (63.64%), BRAF (36.36%), and H3F3A (22.73%) in females (n = 22) and TP53 (26.92%), BRAF (46.15%) and H3F3A (19.23%) in males (n = 26), respectively. In the 21-40 age group, the gene mutation rates of TP53, IDH1, and TERT were 71.43%, 58.57%, and 21.43% in female (n = 70), whereas these genes ( TP53, 72.90%; IDH1, 63.55%; TERT, 35.51%) displayed higher mutation frequency in males (n = 107). In the 41-60 age group, TERT (61.70%), TP53 (43.97%), and IDH1 (36.88%) in females (n = 141) showed obvious difference compared with that ( TERT, 54.33%; TP53, 47.12%; IDH1, 42.31%) in male (n = 208). Aged patients, especially those over 61 years, the most mutated genes were TERT (63.08%), EGFR (60.00%), and TP53 (49.23%) in female (n = 65), respectively. However, the most commonly mutated genes in male presented apparently different than the genes in female such as LRP1B, CSMD3, SYNE1, NF1, ATM, PTEN, RB1, TERT, MET, and TP53. (2) Generally, the peak incidence of patients with glioma is between 41-60 years old. We found the percentage of the total incidence of glioma patients was associated with the family history (positive, 56.25%; negative, 47.68%). Conclusions: The gene mutated rates were depending on the age, sex, and family history in glioma, which might reveal potential effect for biomarker detection in combination with these categories in clinical." @default.
- W4379285871 created "2023-06-05" @default.
- W4379285871 creator A5013514110 @default.
- W4379285871 creator A5016182930 @default.
- W4379285871 creator A5029042360 @default.
- W4379285871 creator A5031172404 @default.
- W4379285871 creator A5037114145 @default.
- W4379285871 creator A5054464310 @default.
- W4379285871 creator A5063179713 @default.
- W4379285871 date "2023-06-01" @default.
- W4379285871 modified "2023-10-15" @default.
- W4379285871 title "Mutation profiling of gliomas based on sex, age, and family history." @default.
- W4379285871 doi "https://doi.org/10.1200/jco.2023.41.16_suppl.e14041" @default.
- W4379285871 hasPublicationYear "2023" @default.
- W4379285871 type Work @default.
- W4379285871 citedByCount "0" @default.
- W4379285871 crossrefType "journal-article" @default.
- W4379285871 hasAuthorship W4379285871A5013514110 @default.
- W4379285871 hasAuthorship W4379285871A5016182930 @default.
- W4379285871 hasAuthorship W4379285871A5029042360 @default.
- W4379285871 hasAuthorship W4379285871A5031172404 @default.
- W4379285871 hasAuthorship W4379285871A5037114145 @default.
- W4379285871 hasAuthorship W4379285871A5054464310 @default.
- W4379285871 hasAuthorship W4379285871A5063179713 @default.
- W4379285871 hasConcept C104317684 @default.
- W4379285871 hasConcept C121608353 @default.
- W4379285871 hasConcept C126322002 @default.
- W4379285871 hasConcept C127848430 @default.
- W4379285871 hasConcept C143998085 @default.
- W4379285871 hasConcept C2778227246 @default.
- W4379285871 hasConcept C2781179581 @default.
- W4379285871 hasConcept C501734568 @default.
- W4379285871 hasConcept C502942594 @default.
- W4379285871 hasConcept C54355233 @default.
- W4379285871 hasConcept C71924100 @default.
- W4379285871 hasConcept C86803240 @default.
- W4379285871 hasConceptScore W4379285871C104317684 @default.
- W4379285871 hasConceptScore W4379285871C121608353 @default.
- W4379285871 hasConceptScore W4379285871C126322002 @default.
- W4379285871 hasConceptScore W4379285871C127848430 @default.
- W4379285871 hasConceptScore W4379285871C143998085 @default.
- W4379285871 hasConceptScore W4379285871C2778227246 @default.
- W4379285871 hasConceptScore W4379285871C2781179581 @default.
- W4379285871 hasConceptScore W4379285871C501734568 @default.
- W4379285871 hasConceptScore W4379285871C502942594 @default.
- W4379285871 hasConceptScore W4379285871C54355233 @default.
- W4379285871 hasConceptScore W4379285871C71924100 @default.
- W4379285871 hasConceptScore W4379285871C86803240 @default.
- W4379285871 hasIssue "16_suppl" @default.
- W4379285871 hasLocation W43792858711 @default.
- W4379285871 hasOpenAccess W4379285871 @default.
- W4379285871 hasPrimaryLocation W43792858711 @default.
- W4379285871 hasRelatedWork W1972804622 @default.
- W4379285871 hasRelatedWork W2068588654 @default.
- W4379285871 hasRelatedWork W2115007886 @default.
- W4379285871 hasRelatedWork W2135257384 @default.
- W4379285871 hasRelatedWork W2303464974 @default.
- W4379285871 hasRelatedWork W3030671992 @default.
- W4379285871 hasRelatedWork W3031738586 @default.
- W4379285871 hasRelatedWork W4280501330 @default.
- W4379285871 hasRelatedWork W4315629143 @default.
- W4379285871 hasRelatedWork W4361213001 @default.
- W4379285871 hasVolume "41" @default.
- W4379285871 isParatext "false" @default.
- W4379285871 isRetracted "false" @default.
- W4379285871 workType "article" @default.